A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

With an increased confidence in the company’s prospects, HSBC raised its earnings estimates for Biocon, projecting ...

Insulet stock is near a buy point after gapping up on earnings. The company increased its full year sales guidance.

After the clearance from US drugs regulator, Motilal Oswal has upgraded Biocon to 'buy' with a target price of Rs 430 apiece.

When you have diabetes, insulin is vital to help keep your blood sugar levels in check. If you have type 1 diabetes, you must inject insulin daily. Those with type 2 diabetes may also require ...

Let’s not demonize carbohydrates and insulin. Carbohydrates are beneficial for fueling the body for exercise and demanding ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Insulet (PODD – Research Report). The company’s shares closed ...

Polycystic ovary syndrome (PCOS) can put you at risk for insulin resistance. Watch for symptoms of insulin resistance that are common for females with PCOS. These include cravings and frequent ...

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

H.C. Wainwright analyst Joseph Pantginis has maintained their bullish stance on BMEA stock, giving a Buy rating yesterday.Stay Ahead of the ...